31.https://go.drugbank.com/drugs/DB14919 32.https://go.drugbank.com/drugs/DB18704 33.https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-talvey-talquetamab-tgvs-relapsed-or-refractory-multiple 34.https://go.drugbank.com/drugs/DB15766 35.h...
These stimulants are controlled substances approved for short-term use in weight loss, usually only up to 12 weeks maximum. As with other weight loss treatments, these drugs should be used in conjunction with ongoing diet and exercise to maintain weight loss....
Now, the Food and Drug Administration(FDA) has approved two drugs that may slow the cognitive decline destroying the lives of millions of Alzheimer’s patients. But both approvals are highly controversial. They were only based on the drugs’ ability to remove plaques (斑块), which were thought...
Ohta, Y. and Shinkai, Ichiro, New Drugs--Reports of New Drugs Recently Approved by the FDA, Lamivudine, Bioorganic & Medicinal Chemistry, 1997, 5, 639-640.New drugs--reports of new drugs recently approved bythe FDA lamivudine. Ohta, Y,I Shinkai. Bioorganic and Medicinal Chemistry . 1997...
回顾2024年,全球医药研发的活力依旧旺盛,为抗肿瘤治疗领域交出了众多耀眼的成绩单。在这一年里,美国食品药品监督管理局(FDA)共批准或修订抗肿瘤适应证56项,涵盖肺癌、血液系统肿瘤、甲状腺癌、乳腺癌、结直肠癌等多个高关注度癌种,本文将按癌种对2024年...
Ahead of us in June,it is anticipated FDA will make decisions on the following four drugs. Drug: spesolimab Company: Boehringer Ingelheim Indication: generalized pustular psoriasis Boehringer Ingelheim’s spesolimab is a humanized, selective antib...
The FDA in 2011 announced years' worth of studies from a major drug research lab were potentially worthless, but it has not pulled any of the compounds from the market nor identified them
The US Food and Drug Administration (FDA) Office of Generic Drugs has reported improvements in the number of generic drugs approved in its 2023 Annual Report, and detailed deficiencies that applicants needed to resolve before an approval could be made. ...
Drugs@FDA: FDA-Approved Drugs Drugs@FDA: FDA-Approved Drugs[1] Drugs@FDA: FDA-Approved Drugs[2] globalpharmacyplus.com - 631427 - 12/27/2022 | FDA[3] Drugs@FDA: FDA-Approved Drugs[4] 参考 ^Drug Databases Drugs@FDA Drugs@FDA: FDA-Approved Drugs https://www.accessdata.fda.gov/scripts...
in Japan and certain countries in Asia and Latin America for acid-related diseases. If approved in the US, the company anticipates launching the two vonoprazan-based regimens as early as H2 2022, to offer new treatment options to address the declining H pylori eradication rates. Recently, Phath...